Latest Articles

Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

BOSTON and CARSLBAD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced the closing of the exclusive licensing agreement with Pfizer Inc. (NYSE:) for AKCEA-ANGPTL3-LRx  following expiration of the waiting period under […]

Quest Solution Announces Name Change to OMNIQ Corp. and Reverse Stock Split

Quest Solution Announces Name Change to OMNIQ Corp. and Reverse Stock Split

Reverse split undertaken with the intent to uplist to a national securities exchange New name better expresses Company’s heightened focus on enhancing leadership position as AI-Machine vision solutions provider SALT LAKE CITY, Nov. 18, 2019 (GLOBE NEWSWIRE) — Quest Solution, Inc. (OTCQB: QUES) (“Quest” or “the Company”), announced that it […]

LHC Group to Present at the 2019 Jefferies London Healthcare Conference

LHC Group to Present at the 2019 Jefferies London Healthcare Conference

LAFAYETTE, La., Nov. 18, 2019 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019 at 9:20 a.m. Greenwich Mean Time and a will be available. To access the live […]

Analysts are Saying Buy This Stock: Formula One Group (:FWONA)

Wall Street brokerage firm analysts have placed a “Buy” rating on shares of Formula One Group (:FWONA).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 2.10 on the shares.  Based on a recent trade, the […]

Analysts Have Spoken & Consensus Is in for Qumu Corporation (NASDAQ:QUMU)

Research brokerage firms on Wall Street are offering a consensus “Buy” rating on shares of Qumu Corporation (NASDAQ:QUMU).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.50 on the shares.  Based on a recent trade, […]

Analysts Are Saying Buy This Stock: Satsuma Pharmaceuticals, Inc. (:STSA)

Wall street brokerage firm analysts are offering a consensus “Buy” rating on shares of Satsuma Pharmaceuticals, Inc. (:STSA).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.50 on the shares.  Based on a recent trade, […]

Consensus Buys According to Analysts: Adial Pharmaceuticals, Inc. (:ADIL)

Sell-side analysts are offering a consensus “Buy” rating on shares of Adial Pharmaceuticals, Inc. (:ADIL).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 2.00 on the shares.  Based on a recent trade, the shares are […]

What is the Sell-side Recommending for Systemax Inc. (NYSE:SYX)

Brokerage firms covering shares of Systemax Inc. (NYSE:SYX) have given the stock a “Buy” rating on a consensus basis.  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.00 on the shares.  Based on a […]